| Literature DB >> 29758946 |
Zhen-Qian Zhuang1, Lin-Lin Shen1, Wei-Wei Li1, Xue Fu2, Fan Zeng1, Li Gui3, Yang Lü2, Min Cai4, Chi Zhu1, Yin-Ling Tan5, Peng Zheng6, Hui-Yun Li1, Jie Zhu1, Hua-Dong Zhou1, Xian-Le Bu1, Yan-Jiang Wang1.
Abstract
Previous studies suggest that gut microbiota is associated with neuropsychiatric disorders, such as Parkinson's disease, amyotrophic lateral sclerosis, and depression. However, whether the composition and diversity of gut microbiota is altered in patients with Alzheimer's disease (AD) remains largely unknown. In the present study, we collected fecal samples from 43 AD patients and 43 age- and gender-matched cognitively normal controls. 16S ribosomal RNA sequencing technique was used to analyze the microbiota composition in feces. The composition of gut microbiota was different between the two groups. Several bacteria taxa in AD patients were different from those in controls at taxonomic levels, such as Bacteroides, Actinobacteria, Ruminococcus, Lachnospiraceae, and Selenomonadales. Our findings suggest that gut microbiota is altered in AD patients and may be involved in the pathogenesis of AD.Entities:
Keywords: 16S ribosomal RNA sequencing; Alzheimer’s disease; amyloid-β peptide; gut microbiota
Mesh:
Substances:
Year: 2018 PMID: 29758946 DOI: 10.3233/JAD-180176
Source DB: PubMed Journal: J Alzheimers Dis ISSN: 1387-2877 Impact factor: 4.472